SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

Cervical cancer jab researcher warns of risks

By Leave a Comment

Irish Examiner.com

By Jennifer Hough

Monday, August 30, 2010

THE leading researcher in the development of the cervical cancer vaccine, Gardasil, has called it a “public health experiment” and has warned that parents must be made aware of the serious adverse events associated with its use.

The vaccination programme is set to be rolled out here next month, targeting first- and second-year secondary school students.

However, Dr Diane Harper, who carried out safety studies to get Gardasil approved, warned of “serious adverse events including death” associated with it.

The Gardasil Debate: Cervical Cancer

By Leave a Comment

Ethiopian Review

August 30th, 2010 at 12:34 am |
Waterford Today
Ireland

Cervical cancer is the second leading cause of death from cancer world-wide. (Bridges, 2008) It is also the leading cause of cancer related deaths in the developing countries. (National Cervical Cancer Coalition) Ireland has one of the highest cervical cancer death rates in Western Europe and this rate is increasing by 1.5% per year. (The Irish Cancer Society, 2008 and Condon, D. 2005.) The implementation of a nationwide cervical screening programme for all women aged 25-60 years is called upon- urgently. Such a programme would reduce the incidence of cervical cancer by 80 %.( I.C.S. 2007) In the meantime the introduction of the Gardasil injection targeted initially towards the 9-26year old paves the way for reductions in the current trends for the future.

The Great HPV Vaccine Hoax Exposed

By Leave a Comment

NaturalNews

August 2010

For the last several years, HPV vaccines have been marketed to the public and mandated in compulsory injections for young girls in several states based on the idea that they prevent cervical cancer. Now, NaturalNews has obtained documents from the FDA and other sources (see below) which reveal that the FDA has been well aware for several years that Human Papilloma Virus (HPV) has no direct link to cervical cancer.

T-cell response to human papillomavirus type 58 L1, E6 and E7 peptides in women with cleared infection, cervical intraepithelial neoplasia and invasive cancer

By Leave a Comment

PubMed.gov
Clin Vaccine Immunol. 2010 Jul 28. [Epub ahead of print]

Human papillomavirus (HPV) 58 exists in a relatively high prevalence in certain parts of the world including East Asia. This study examined T-cell response to HPV 58 L1, E6 and E7 peptides among women with cleared infection, cervical intraepithelial neoplasia (CIN) grade 2 and 3, and invasive cervical cancer (ICC).

From Human Papillomavirus to Cervical Cancer

By Leave a Comment

American College of Obstetrics and Gynecology

July 2010

Mark Schiffman, MD, MPH, and Nicolas Wentzensen, MD, PhD

Cervical cancer is one of the most common female
malignancies worldwide; 80% of cases occur in
low-resource regions.1,2 Screening programs have been
very successful in the United States, Europe, and other
regions able to achieve broad and sustained coverage. In
the United States, the disease is controlled at an annual
cost of billions of dollars representing a major commitment
by patients and clinicians.

News

Videos

Contact